Editorial Comment: Abbreviated Breast MRI—Good, but Not All the Same

2022 ◽  
Author(s):  
Mariam Thomas
Keyword(s):  
Editorial Comment ◽  
Breast Mri ◽  
Abbreviated Breast Mri

scholarly journals Abbreviated Breast MRI for Screening High-Risk Women: Comparison with the Full Clinical Protocol

2020 ◽  
Author(s):  
Kendrah V Osei ◽  
Anita K Mehta ◽  
Denise M Thigpen ◽  
Jocelyn Rapelyea ◽  
Steven Friedman ◽  
...  
Keyword(s):  
High Risk ◽  
Cancer Detection ◽  
Breast Mri ◽  
Recall Rate ◽  
Report Generation ◽  
High Risk Women ◽  
Patient Recall ◽  
Abbreviated Breast Mri ◽  
Student’S T ◽  
Mri Study

Abstract Objective To compare cancer detection rate (CDR), patient recall, and interpretation time of a full protocol MRI (fpMRI) to an abbreviated MRI protocol (abMRI) in high-risk women. Methods This retrospective study was approved by the IRB. All sequential high-risk screening MRI examinations performed between January 1, 2013, and December 31, 2016, were included. Breast radiologists reviewed patient history, prior images, and abMRI images and recorded their interpretation. Time for interpretation reflected review of the MRI study but not dictation or report generation. Following a minimum 30-day washout period, radiologists interpreted the fpMRI, with interpretation and timing recorded. Data collected included CDR, interpretation time, and patient recall rate. Statistical analyses utilized were Cohen’s kappa coefficient, Student’s t-test, and McNemar’s test. Results Included were 334 MRI examinations of 286 women. Interpretation time was 60.7 seconds for the abMRI compared to 99.4 seconds for the fpMRI, with an average difference of 38.7 ± 5.4 seconds per patient (P < 0.0001). Recall rates were comparable: the abMRI recall rate was 82/334 (24.6%) and the fpMRI 81/334 (24.3%). All five cancers included were detected by both protocols with equal recall rate. However, there were more recommendations for biopsy with the fpMRI, although this difference was not statistically significant. Conclusion The abMRI demonstrated comparable CDR to fpMRI, with shortened interpretation time and similar recall rates. Implementing an abMRI to screen high-risk women reduces imaging and interpretation time, thereby improving cost-effectiveness and the patient experience without reduction in cancer detection.

scholarly journals Correction to: Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery

2017 ◽  
Vol 167 (2) ◽  
pp. 503-503
Author(s):  
Bo Hwa Choi ◽  
Nami Choi ◽  
Mi Young Kim ◽  
Jung-Hyun Yang ◽  
Young Bum Yoo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Mri ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
History Of ◽  
Abbreviated Breast Mri

scholarly journals The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis

2021 ◽  
Vol 76 (2) ◽  
pp. 154.e11-154.e22 ◽  
Author(s):  
R. Geach ◽  
L.I. Jones ◽  
S.A. Harding ◽  
A. Marshall ◽  
S. Taylor-Phillips ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Meta Analysis ◽  
Breast Mri ◽  
Potential Utility ◽  
Fast Mri ◽  
Abbreviated Breast Mri

Abbreviated Breast MRI for Estimating Extent of Disease in Newly Diagnosed Breast Cancer

2019 ◽  
Vol 2 (1) ◽  
pp. 43-49 ◽  
Author(s):  
Stephanie Lee-Felker ◽  
Melissa Joines ◽  
Lindsey Storer ◽  
Bo Li ◽  
Nanette DeBruhl ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Predictive Value ◽  
Maximum Intensity Projection ◽  
Breast Mri ◽  
Newly Diagnosed ◽  
Institutional Review ◽  
Abbreviated Breast Mri ◽  
Magnetic Resonance Imaging Mri ◽  
Extent Of Disease ◽  
Mean Sensitivity

Abstract Objective To evaluate extent of disease estimation of abbreviated protocol (ap) magnetic resonance imaging (MRI) compared with full protocol (fp) MRI in newly diagnosed breast cancer. Methods In this institutional review board–approved, Health Insurance Portability and Accountability Act–compliant, retrospective study of women with breast cancer who underwent pretreatment fpMRI on a 3 Tesla MRI in 2013, axial fat-saturated pre- and first postcontrast T1, maximum-intensity projection, and subtraction sequences were interpreted independently by three breast radiologists in two sessions, without and with prior imaging, respectively. Agreement was calculated using Cohen’s kappa. Interpretations were compared with histology or clinical stability. Diagnostic performances were compared using Bennett’s statistic. P < 0.05 was significant. Results Eighty-one women (mean age 56 years, range 32–92 years), 116 lesions, and 95 cancers (mean size 27 mm, range 4–110 mm) were included. Agreement among radiologists for lesion assessment was excellent (0.83). apMRI cancer detection improved with prior imaging (mean sensitivity from 95% to 99%, specificity from 91% to 97%, positive predictive value [PPV] from 92% to 98%, and negative predictive value [NPV] from 95% to 99%) versus fpMRI (sensitivity 98% [93/95], specificity 94% [76/81], PPV 95% [93/98], and NPV 97% [76/78]). apMRI detected all multifocal, multicentric, and contralateral disease seen in 19% (15/81) of women to the same extent as fpMRI. apMRI axillary metastases detection improved with prior imaging (mean sensitivity from 78% to 86%, specificity from 90% to 92%, PPV from 76% to 82%, and NPV from 89% to 94%) versus fpMRI (sensitivity 71% [17/24], specificity 88% [51/58]), PPV 71% [17/24], and NPV 88% [51/58]). Conclusion apMRI may be acceptable for women with newly diagnosed cancer.

scholarly journals Randomized Trial of Surveillance with Abbreviated MRI in Breast Cancer Survivors – Does it impact patient anxiety and cancer detection rate?

2021 ◽  
Author(s):  
Jean Morag Seely ◽  
Marina Mohallem Fonseca ◽  
Tasmeen Alhassan ◽  
Yashmin Nisha ◽  
Diana Koszycki ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Cancer Detection ◽  
Breast Cancer Survivors ◽  
Controlled Trial ◽  
Breast Mri ◽  
Patient Anxiety ◽  
Exact Test ◽  
Academic Center ◽  
Abbreviated Breast Mri

Abstract Purpose: Abbreviated breast MRI substantially reduces the image acquisition and reading times and has been reported to have similar diagnostic accuracy as a full diagnostic protocol but has not been evaluated prospectively with respect to impact on patient anxiety in breast cancer survivors and cancer outcomes.Methods: This prospective controlled trial of parallel design was performed at an academic center on women with a personal history of breast cancer who were randomized into two groups: surveillance with MG or MG plus A-MRI. Primary outcome was anxiety compared between the two and measured by four validated questionnaires at three different time-points during the study. Other parameters including the CDR, abnormal interpretation rate (AIR), and positive predictive value for biopsy (PPV3) were compared between modalities of MG and A-MRI. Tissue diagnoses or 1 year of follow-up were used to establish the reference standard. Linear mixed models were used to analyze anxiety and Fisher’s exact test to compare imaging outcomes.Results: 198 patients were allocated to either MG alone (94) or A-MRI plus MG (104). Anxiety scores in all questionnaires were similarly elevated in both groups (50.99+/-4.6 with MG vs 51.73+/-2.56 with MRI,p>0.05) and did not change over time. MRI detected 5 invasive cancers and 1 DCIS, and MG detected 1 DCIS. MRI had higher incremental CDR(48/1000(5/104) vs MG 5/1000(1/198,p=0.01)) and higher AIR 25%(26/104) vs MG 4.5%(9/198,p<0.00001), with no difference in PPV3:MRI 28.6%(6/21)vs MG 16.7%(1/6,p=0.557).Conclusion:Compared to mammography alone, A-MRI had significantly higher incremental cancer detection in breast cancer survivors. Despite a higher rate of recalls and biopsies, A-MRI had no adverse impact on anxiety.

Abbreviated Breast MRI: Road to Clinical Implementation

2020 ◽  
Vol 2 (3) ◽  
pp. 201-214 ◽  
Author(s):  
Laura Heacock ◽  
Beatriu Reig ◽  
Alana A Lewin ◽  
Hildegard K Toth ◽  
Linda Moy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Detection ◽  
Breast Mri ◽  
High Sensitivity ◽  
Clinical Implementation ◽  
Patient Tolerance ◽  
Key Issues ◽  
Abbreviated Breast Mri ◽  
Multicenter Clinical Trials

Abstract Breast MRI offers high sensitivity for breast cancer detection, with preferential detection of high-grade invasive cancers when compared to mammography and ultrasound. Despite the clear benefits of breast MRI in cancer screening, its cost, patient tolerance, and low utilization remain key issues. Abbreviated breast MRI, in which only a select number of sequences and postcontrast imaging are acquired, exploits the high sensitivity of breast MRI while reducing table time and reading time to maximize availability, patient tolerance, and accessibility. Worldwide studies of varying patient populations have demonstrated that the comparable diagnostic accuracy of abbreviated breast MRI is comparable to a full diagnostic protocol, highlighting the emerging role of abbreviated MRI screening in patients with an intermediate and high lifetime risk of breast cancer. The purpose of this review is to summarize the background and current literature relating to abbreviated MRI, highlight various protocols utilized in current multicenter clinical trials, describe workflow and clinical implementation issues, and discuss the future of abbreviated protocols, including advanced MRI techniques.

Sign in / Sign up

Export Citation Format

Share Document